N@N

Natunola Releases Q1 2009 Results

  //house-home.news-articles.net/content/2009/05/25/natunola-releases-q1-2009-results.html
  Published in House and Home on Monday, May 25th 2009 at 14:42 GMT, Last Modified on 2009-05-25 14:43:07 by Market Wire

 WINCHESTER, ON, May 25 /CNW Telbec/ - Natunola Health Biosciences Inc. (TSX-V:NHI) ("Natunola") reports that the sales for the three months ended on March 31, 2009 was $281,688 as compared to $626,662 for the comparative period for 2008, which represented a decrease of $344,974 or 55%. The decrease in revenue is due to the economic slow down and the decrease in sales to several customers. As a result, the Company had a net loss of $130,605 or -$0.01 per share for the three months ended March 31, 2009. The sales for the Company's personal care product lines decreased by 24.4% or $25,036 for the three months ended March 31, 2009 versus the comparative period for 2008. The decline is a result of fewer orders in Q1 2009. The sales for the Company's flax product lines decreased by 61% or $319,938 for the three months ended March 31, 2009 versus the comparative period for 2008. The decline is a result of fewer orders and decrease in sales to specific customers in Q1 2009. Many of the Company's customers are either contract manufacturers or manufacturers who are affected by the global economic slow down. However, the management believes the situation should improve and the revenue should pick up as the orders and shipments for months of April and May (to date) are encouragingly higher. Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release. %SEDAR: 00009761E 

For further information: Dr. Murray McLaughlin, Chairman, Natunola Health Biosciences Inc., (613) 774-0008